The Next Shift in Dental Manufacturing Is Inside the Bottle
Printers get the attention. But Dr. Martin Klare’s work points to a deeper shift: the chemistry inside the resin may determine how far digital dentistry can go.
Editor in Chief
Executive Abstract
The migration of dental 3D printing from a prototyping novelty to a primary manufacturing infrastructure is fundamentally dependent on materials science. While hardware improvements have dominated industry headlines, the true operating system of digital dentistry is increasingly found in the photopolymer chemistry within the resin bottle. This article analyzes the strategic approach of pro3dure medical GmbH and its CEO, Dr. Martin Klare, in developing validated, indication-specific material systems. It examines the critical role of biocompatibility, regulatory documentation (ISO 13485, FDA 510(k)), and functional technologies like Multi-Species Inhibition (MSI) in establishing clinical trust. The conclusion suggests that the next phase of industry value will shift from printer speed to material system validation and the ability to own specific clinical indications through documented workflows.
Quick Answer
The real innovation in dental 3D printing is shifting from the printer to the material. Companies like pro3dure medical are moving beyond selling generic resins to providing validated material systems for specific uses like surgical guides, splints, and dentures. By focusing on biocompatibility, regulatory compliance, and anti-biofilm technology, they are turning materials science into a trusted operating layer that ensures safe and predictable clinical outcomes.
Key Findings
- Material Defines the Workflow: In dental manufacturing, the physical properties of the resin determine the success of the clinical indication, from surgical survival to patient compliance.
- Validation as a Competitive Moat: As printers become commoditized, the primary differentiator for material providers is regulatory credibility (FDA 510(k)) and validated production protocols.
- The Indication-Specific Stack: Leading companies are building materials stacks across the lab, owning the entire workflow for specific products like splints or dentures rather than just selling bottles.
- Functional Chemistry (MSI): Differentiated technologies like Multi-Species Inhibition address persistent clinical problems like biofilm adhesion, shifting the focus from "printing faster" to "behaving better" in the mouth.
- The Informational Material: Future dental materials require a complete data trail—CAD settings, printer parameters, and IFUs—to be successfully adopted by modern laboratories.
The Material is the Workflow
The easiest way to underestimate pro3dure medical GmbH is to put it in the wrong category. At first glance, it looks like another dental materials company: bottles of resin, milling blanks, instructions for use, product names with numbers, and the familiar alphabet soup of regulatory claims. But look closer and a different picture emerges.
pro3dure is not really organized around "products." It is organized around use cases: surgical guides, splints, orthodontic appliances, denture bases, try-ins, temporary restorations, radiographic templates, gingiva masks, dental models, and CAD/CAM milling blanks. That distinction matters. A product company sells material. A workflow company tries to make the material disappear into the process.
Digital dentistry often gets narrated as a software story—intraoral scanners, CAD design, cloud libraries, automated nesting, and AI treatment planning. It is easy to think the physical material is just the last step: a consumable that turns the digital plan into something tangible. That is wrong. In dental manufacturing, the material is not downstream of the workflow. The material defines the workflow.
A resin determines whether a guide can survive surgery. A splint material determines whether a patient will actually wear the appliance. A temporary crown material determines how long the restoration can remain intraorally. A denture-base material determines fit, fracture resistance, polishability, and hygiene.
The Dental Portfolio is Broader Than It Looks
The company says it has more than 10 years of expertise, more than 300 products, and distribution in more than 30 countries. Its dental portfolio includes the printodent family of 3D-printing resins and milling-disc products such as THERMEO and PRO3dent splint.
That breadth is strategically important. Many dental materials companies pick one lane: model resin, splint resin, denture resin, temporary resin, or milling discs. pro3dure instead appears to be building a materials stack across the lab. A lab does not wake up wanting "a resin." It wants a guide system, a splint system, a denture system, a model system, or a temporary-restoration system that works reliably enough to put into production.
The company's download infrastructure reinforces the same point. Its instructions-for-use page lists multilingual IFUs for numerous printodent materials and milling blanks. For a serious dental lab, instructions for use are not paperwork. They are the difference between "we tried a resin" and "we can build a repeatable production workflow around it."
Klare’s Old Research Explains the Company’s Current Shape
Dr. Martin Klare, listed by pro3dure as CEO, is not a conventional dental-sales founder. His background runs through chemistry, photocatalysis, photopolymers, rapid manufacturing, biocompatibility, and dental additive manufacturing.
One of his most directly relevant later papers is "Biocompatibility of photopolymers for additive manufacturing," a 2016 article that studied leachable substances in cured photopolymeric systems and tested cytotoxicity and genotoxicity under ISO 10993-related methods. That paper reads like the scientific skeleton underneath a dental resin business.
Dental 3D-printing materials live or die on questions that are not obvious to the end customer. What leaches out after curing? What happens if the material is under-cured? How does post-curing alter biological and mechanical performance? What happens in long-term mucosal contact? What is the boundary between a model material and an intraoral device material?
The Moat is Not 3D Printing. The Moat is Validation.
The dental 3D-printing market has been crowded for years. Printers have become cheaper. Resin brands have multiplied. The low end of the market is structurally hard: prices compress, distributors multiply, and "good enough" materials become interchangeable.
pro3dure's apparent response is to move away from the commodity center. Its strongest defensibility is not that it makes resin. It is that it builds around validated, indication-specific, regulated material systems.
The FDA trail is a useful proof point. FDA documentation for K201827 identifies pro3dure's GR-17 Resin System as a light-curable polymerizable resin system for additively manufactured temporary dental restorations and preformed denture teeth. Another FDA record, K212017, relates to pro3dure's THERMEO System for dental appliances such as mouthguards, nightguards, bruxism splints, TMJ splints, and bite splints.
FDA 510(k) clearance is not a magic wand, and it is not the same as drug-style "approval." But it does separate a regulated intraoral appliance material from a resin that merely prints nicely.
MSI is the Most Interesting Bet
The most differentiated part of pro3dure's story is MSI, or Multi-Species Inhibition. pro3dure describes MSI as a functional technology used in 3D-printing resins and milling blanks, with anti-biofilm positioning.
Strategically, MSI is interesting because it addresses one of the least glamorous but most persistent problems in removable dental appliances: biofilm. Splints smell. Nightguards accumulate plaque. Dentures become hygiene challenges. A material that can reduce biofilm adhesion or improve hygiene would not just be a material upgrade. It would be a patient-compliance upgrade.
The caveat is important: marketing claims around antimicrobial, anti-biofilm, or hygiene-enhancing materials always need careful scrutiny. The strongest next layer of evidence would be independent clinical or real-world lab studies showing measurable reductions in plaque, odor, remake rates, hygiene complaints, or appliance abandonment.
The Exocad Partnership and the Informational Material
In 2021, pro3dure announced a partnership with exocad to integrate the entire printodent family of 3D-printing materials into exocad's cloud-based materials database. This is one of those announcements that looks minor until you think like a lab.
Dental labs do not want isolated products. They want materials that show up in the software, map to the right indication, connect to printer parameters, produce predictable outputs, and require minimal tribal knowledge. A material that lives inside a CAD/CAM workflow is easier to adopt than one that sits outside it.
What pro3dure is Really Selling
The obvious answer is dental materials. The better answer is confidence.
Confidence that a resin is biocompatible for its intended use. Confidence that a splint material can survive the mouth. Confidence that the workflow is documented. Confidence that the material exists inside the software ecosystem. Confidence that the company understands the regulatory burden of intraoral devices.
That is what sophisticated labs buy. They do not just buy price per kilogram. They buy fewer remakes. Fewer surprises. Fewer uncomfortable conversations with dentists. Fewer process variables.
Original Insight
The value in digital dentistry is migrating from the machine to the material system. As hardware becomes a commodity, the "confidence layer"—the technical, regulatory, and workflow validation packed into each bottle—becomes the only defensible premium. The resin bottle is not the product. The product is the confidence that the lab can build a business on top of it.
Clinical and Industry Implications
For Dental Professionals
Clinicians must look beyond "3D printed" as a generic label and ask about the specific resin class and its clinical evidence. The choice of material directly impacts patient compliance, hygiene, and long-term restorative success.
For Dental Laboratories
Labs should prioritize materials that offer complete "instruction-for-use" (IFU) ecosystems and validated software integrations. A cheap resin without a data trail can become expensive due to remakes and regulatory risk.
For Manufacturers
Material companies must shift from selling consumables to providing "indication-as-a-service," where the bottle comes with validated printer settings, post-processing rules, and clinical documentation.
For Software Companies
CAD/CAM platforms must deepen their integration with material databases, ensuring that design parameters (like minimum thickness) are automatically synced with the specific properties of the chosen resin.
For Investors
The next wave of investment will favor "chemistry-first" companies that own the IP for functional materials, rather than hardware companies whose margins are being squeezed by global competition.
What Remains Uncertain
While functional technologies like MSI are promising, long-term independent clinical data showing measurable improvements in patient outcomes (e.g., reduced odor or plaque) is still emerging. Additionally, as the market becomes more crowded, the ability of smaller specialized material companies to maintain a dominant distribution footprint in North America against entrenched incumbents remains a significant operational challenge. Workflow friction is also a risk: even the best material can fail commercially if labs find the post-processing too fussy or the printer compatibility too narrow.
Definitions
- Photopolymer
- A polymer that changes its properties (typically hardening) when exposed to light, forming the basis of resin-based 3D printing.
- Biocompatibility
- The ability of a material to perform with an appropriate host response in a specific application, essential for any device used in the oral cavity.
- MSI (Multi-Species Inhibition)
- A technology designed to prevent the formation of complex microbial communities (biofilms) on the surface of dental appliances.
- ISO 13485
- The international standard for a quality management system specifically for the design and manufacture of medical devices.
Frequently Asked Questions
What is MSI technology in dental resins?
MSI (Multi-Species Inhibition) is a functional technology used in pro3dure's 3D-printing resins and milling blanks designed to inhibit biofilm adhesion, potentially improving appliance hygiene and patient compliance.
Why is material validation important for digital labs?
Validation ensures that a material is biocompatible for its intended use and that the manufacturing workflow (printer, wash, cure) produces a safe and effective clinical result.
What is the difference between a model resin and an intraoral resin?
Model resins are used for physical replicas and are not biocompatible for mouth use. Intraoral resins (for guides, splints, or dentures) must meet strict regulatory and biocompatibility standards like ISO 10993.
How does post-curing affect 3D-printed restorations?
Post-curing is a critical step that completes the polymerization process, determining the final mechanical properties and biocompatibility of the printed object.
Is 3D printing replacing milling in dental labs?
No. Modern labs use both additive (printing) and subtractive (milling) manufacturing, selecting the best process based on the specific material requirements and clinical indication.
Citation-Ready Summary
"The dental 3D printing market is transitioning from hardware-centric novelty to material-driven infrastructure. The strategic focus of companies like pro3dure medical indicates that clinical success is increasingly determined by indication-specific photopolymer chemistry and validated production workflows. By integrating regulatory compliance (FDA 510(k)) and functional technologies like MSI directly into the material system, the industry is moving toward a more responsible and predictable era of digital manufacturing."
Source Notes & References
- pro3dure medical GmbH - Official Website and Product Catalog.
- FDA 510(k) K201827 - pro3dure GR-17 Resin System Regulatory Record.
- FDA 510(k) K211415 - GR Splint Resin System.
- FDA 510(k) K212017 - THERMEO System for dental appliances.
- FDA 510(k) K231775 - GR Resin System MSI.
- Leonhardt et al. - "Biocompatibility of photopolymers for additive manufacturing," Current Directions in Biomedical Engineering, 2016.
- pro3dure MSI Technology - Anti-biofilm Functional Materials Overview.
- exocad and pro3dure strategic partnership announcement (2021).
- pro3dure medical & Gro3X North American distribution partnership (2020).
- pro3dure MDR certificate milestone announcement.
About the Author
Norbert Ulmer is the founder of DentalRevolution.ai™ and CEO of Gro3X.
Over the past three decades he has worked across Europe, Asia, and North America in leadership roles spanning dental technology, digital workflows, CAD/CAM, manufacturing, and business strategy.
Today he focuses on helping dental professionals understand how artificial intelligence, automation, software, and connected workflows are transforming dentistry.